A New Kind of HIV Pill Just Passed Its First Test in Humans
3 Articles
3 Articles
A New Kind of HIV Pill Just Passed Its First Test in Humans
Scientists have just announced the results from the first clinical trial in people with HIV-1 of a new antiretroviral drug, which suggests it could be a very useful new tool in treating the virus.
Between 26 and 31 July, the 26th International AIDS Conference took place in Rio de Janeiro, Brazil. On this occasion, the health NGO "Doctors Without Borders" (Médecins sans frontieres, MSF) criticized the pharmaceutical manufacturer "Gilead" because it does not want to release its HIV drug lenacapavir as a generic medicine for countries with low and medium income. Lenacapavir can be used for both treatment and [...]
Currently in Brazil the 26th international conference on HIV. The biggest topic is still a very promising medication.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium


